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In  1930 (1)  one of us described a  type-specific substance  in  the 
autolysates of Pneumococcus Type I  which caused precipitation in 
homologous antiserum after all precipitating antibody reacting with 
the specific carbohydrate of Heidelberger, Goebel and Avery (2) had 
been  removed by  absorption.  This  antigen  which appeared  to  be 
non-protein was provisionally designated the A substance.  Because 
of its instability on heating in the presence of dilute alkali, which was 
in marked contrast to the stability of the specific carbohydrate under 
the'same conditions, and because of its precipitating and anaphylactic 
reaction  with  specific  antiserum  deprived  of  antibody  capable  of 
reacting with the specific carbohydrate, we at first regarded the A sub- 
stance as a  second and distinct antigenic entity, probably belonging 
to the group of partial antigens or haptenes.  However, the analysis of 
Pappenheimer and  Enders  (3)  on  the  chemical composition of  the 
substance obtained by preserving an acid reaction during all steps in 
the purification of the specific carbohydrate, indicated a close relation- 
ship between the A substance and the specific carbohydrate.  These 
authors found that  the elementary analysis of the product derived 
under the constant condition of a low pH was practically identical with 
that  found  for  the  specific  carbohydrate  isolated  according to  the 
procedure  of  Heidelberger,  Goebel  and  Avery,  during  which  the 
material  is  exposed  to  the  alkaline  action  of  concentrated barium 
hydroxide.  Moreover,  no  significant  difference  was  noted  in  the 
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capacity of the two substances to change the plane of polarized light. 
The carbohydrate obtained under the condition of acidity differed, 
nevertheless,  in  two  respects  from  the  specific  carbohydrate: in 
aqueous solution it failed to precipitate at pH 3.4, the isoelectric point 
of the specific carbohydrate; it reacted by precipitating with antiserum 
after  absorption  with  the  specific  carbohydrate.  Moreover,  the 
capacity to cause precipitation in such an antiserum was removed by 
boiling in dilute alkali.  It was observed that the material thus treated 
with alkali precipitated at pH 3.4 and was able to react to titre with 
antiserum which contained antibody for the  specific  carbohydrate. 
Absorption of a specific antiserum with the A carbohydrate removed 
all  antibodies precipitating either with itself  or  the  specific  carbo- 
hydrate.  These  facts  led to  the  suggestion by  Pappenheimer and 
Enders that  the  specific  carbohydrate of Heidelberger, Goebel  and 
Avery represented a  hydrolytic product of  the A substance.  They 
believed that possibly the A substance more closely approximated the 
specific antigen of Type I pneumococcus as it exists in the living cell. 
During the  course of the experiments which are  recorded in this 
paper, Avery and Goebel (4)  reported that by maintaining  an acid 
reaction during the preparation,  they obtained a  specific  substance 
from Type I  pneumococcus, the precipitating power of which, in the 
presence of an antiserum absorbed with specific  carbohydrate,  was 
removed  by  treatment  with  alkali.  On  elementary  analysis,  the 
material appeared to be identical with the specific carbohydrate.  In 
addition they made the significant observation that this carbohydrate 
contained the acetyl group which was not found in the specific carbo- 
hydrate  and  which was  apparently  split  off  upon  treatment  with 
alkali.  In their study of the immunological  properties of this material, 
these authors showed that injection of small quantities of the acetyl 
polysaccharide actively immunized mice against  an otherwise fatal 
dose of virulent pneumococci, while absorption of an antiserum with 
this carbohydrate appeared to eliminate its protective action in those 
animals--a result not obtained with comparable amounts of the sub- 
stance after treatment with alkali.  In the present paper a study of 
certain immunological aspects of the A substance purified according 
to the procedure described by Pappenheimer and Enders (3)  is pre- 
sented. JOHN  ~F.  ENDERS  AND  CHAO-JEN  WU  129 
In particular the action of the substance was investigated in phago- 
cytic systems containing normal opsonins, in bactericidal systems of 
leucocytes and normal and immune sera.  Its capacity to absorb the 
mouse-protective immune body from antiserum as well as its ability 
to induce active immunity in mice, was also examined.  The quan- 
tities necessary to induce such immunity and the time of its appearance 
and  defervescence have been subjected to study.  The sera of mice 
actively immunized  with  the  material  has  been  tested  for  specific 
antibody and the effect of injection of the A substance in A-immunized 
mice on their resistance to pneumococcus infection has been observed. 
The material has  been analyzed chemically to  determine whether 
or not it contains the acetyl group.  This has been found to be present. 
The results serve to identify the A substance as prepared by Pappen- 
heimer and Enders with the acetyl polysaccharide described by Avery 
and Goebel and, in general, to confirm and extend the observations of 
these authors and our own in respect to its immunological effects. 
Materials 
Preparation of the A  Substance.--The  A substance used in these experiments 
was prepared according to the procedure given by Pappenheimer and Enders (3). 
The data obtained on elementary analysis and determination of specific rotation 
have been presented in their report.  Subsequent to the appearance of the paper 
of Avery and Goebel on the acetyl polysaccharide,  this material has been sub- 
jeered to analysis for the presence of the acetyl group according to the method 
of Friedrich and Rapoport (5).  It has been found to contain 5.8 per cent acctyl. 
This finding, taken together with the data of the elementary analysis,  appears to 
offer sufficient reason for concluding  that the acetyl polysaccharide and the A 
carbohydrate arc to be regarded as identical. 
In the majority of experiments, the effect of the A carbohydrate was compared 
with the effect of the substance after boiling in alkaline solution.  As Avery and 
Goebel (4) have shown, such treatment removes the acetyl group.  Deacetyliza- 
tion was effected in N/50 and N/10  concentrations of alkali.  Mter addition of 
the volume of either N/5 or 1 1~ sodium hydroxide required to give these final con- 
centrations to a  measured quantity of 1:100 A carbohydrate, the solution was 
immersed in boiling water for 1 hour and then neutralized with the required amount 
of 1~1/5 or 1 1~1 hydrochloric acid. 
Preparation of Type I  Specific Soluble Substance.--The  specific carbohydrates 
designated as SSS I, SSS II and SSS III were derived from 0.1 per cent dextrose 
phosphate buffer broth cultures of the three types of pneumococcus,  according 
to the procedures described by Heidelberger,  Goebel and Avery. 130  THE  A  SUBSTANCE  OF  PNEU'MOCOCCUS TYPE  I 
Preparation of Antisera.--Three  Type I  antipneumococcus  rabbit sera were 
used.  Of these one was prepared by repeated intravenous injection of pneumo- 
coccus suspension in 0.3  per cent formolized saline.  Antigens employed in the 
production of the remaining two were suspensions of pneumococcus killed by heat- 
ing at 56  ° and 60°C.  The route of administration was intravenous. 
Strains of Pneumococci.--The strain of Type I  pneumococcus used in all the 
experiments was of such virulence that 0.00000005  cc.  of a  6 hour 0.1 per cent 
dextrose infusion broth culture was uniformly fatal for white mice within 48 hours. 
Virulence was maintained by weekly passage through mice.  In a  few cases in 
which control of type specificity was required, stock strains of Type II and III 
pneumococcus were  utilized.  The virulence of  these  for  mice was of the  same 
order as that of the Type I pneumococcus. 
Mice.--White mice varying in weight from 15 to 20 gin. were used. 
Technique 
Technique Employed in Phagocytic Experiments.--Ward and Enders  (6)  have 
described in detail this technique. 
Technique Employed in Bactericidal Experiments.--In the experiments in which 
human defibrinated blood was used as a base for testing the antibactericidal action 
of the A  carbohydrate against the normal antibody of the serum, the technique 
described by Ward (7) was followed, except that 0.25 cc. of defibrinated blood was 
used instead of 0.5 cc.  For the study of the effect of the substance on the bacteri- 
cidal power of immune antibody, a  modification of the technique introduced by 
Robertson and  Sia  (8)  was  developed, in  which  polymorphonuclear leucocytes 
of the rabbit obtained by intrapleural injection of aleuronat, are added to the" 
defibrinated blood of the same animal.  A normal rabbit of about 2 kilos weight 
is injected into the right pleural cavity with 5 cc. of aleuronat suspension, prepared 
according to the direction of Robertson and Sia.  After about 24 hours, 5 cc. of 
1 per cent citrate in saline is injected into the same pleural space and withdrawn 
in the same syringe, together with the exudate of leucocytic cells.  The suspension 
of cells is then slowly centrifuged for 7 minutes and then washed twice with about 
20 cc. of physiological salt solution.  A count of the total white blood ceils present 
is made after resuspension in the second volume of saline, before centrifuging. 
A  quantity of this suspension is removed which,  when  mixed with  the desired 
amount  of rabbit's defibrinated blood, will give a  count  of  10,000  per c.  mm. 
This measured volume of suspension is then slowly centrifuged, the supernatant 
removed and the predetermined quantity of defibrinated blood added to the de- 
posit of cells and well mixed with them.  The number of leucocytes in the blood- 
leucocyte mixture is then checked.  It is usually greater than that found for the 
saline suspension by 1,000  to 2,000  ceils per c. nun.  due to the presence of the 
leucocytes in  the  defibrinated blood.  For satisfactory results,  the final white 
blood count of the mixture should not be below 10,000 per c. mm.  Counts from 
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system.  0.25  cc.  of blood-leucocyte mixture is then placed in small pyrex glass 
tubes (10 cm. long, 7 ram. inside diameter).  1 drop each of antiserum,  carbohy- 
drate and 18 hour blood broth pneumococcus culture, diluted in infusion broth, is 
added in the order named.  After addition of each  substance, the  tube is  gently 
shaken.  The tubes are then sealed and placed in a rotating box (fifteen revolutions 
perhour) at 37°C.  Rotation is  maintained  for 48  hours  when  the  results  are 
read by the darkening of the blood caused by bacterial growth.  These results are 
checked by plating the contents of the last tube in a series  showing color change 
and the first  tube remaining unaffected. 
Technique Employed in Mouse Protection Tests 
A. Passive Immunization with Antipneumococcus  Rabb# Serum.--Equal  vol- 
umes of 6 hour 0.1 per cent dextrose infusion broth culture, diluted 1:20 in broth, 
and  the  various  dilutions  of antiserum  are  well  mixed  and  injected  intraperi- 
toneally into mice in a  total volume of 0.4 cc.  Three animals were  usually em- 
ployed for each dilution of the serum tested.  Mice serving as controls for virulence 
received 0.3 cc. of the culture, diluted to 1 : 10,000,000 and 1 : 10,000,000 in infusion 
broth.  0.1  cc. of these dilutions was plated to indicate the number of pneumo- 
cocci injected.  The animals were considered to have been protected if they  sur- 
vived 8 days. 
B. Active Immunization with the A  Carbohydrate.--The  A  carbohydrate and its 
derivative after treatment with alkali, were diluted in saline.  0.5 cc. of the saline 
dilutions was injected intraperitoneally in mice.  After varying intervals the pres- 
ence of active immunity was determined by injecting 0.5 cc. of 6 hour 0.1  per cent 
dextrose infusion broth culture of pneumococcus, suitably diluted in sterile  broth. 
The animals were observed for a period of 8 days after injection. 
Technique Employed  in Absorbing Antisera  with the A  Carbohydrate, Its  De- 
acetylated Derivative and with Pneumococcus Boiled on the Acid and Alkaline  Sides 
of Neutrality.--Anfibody precipitation with the A carbohydrate, or its derivative 
after boiling in alkali,  was removed from Yneumococcus Type I  antiserum  by 
repeated addition of these antigens and removal of the resulting precipitate.  Pre- 
liminary  titrations  were  done  to  determine  the  quantity  of the  carbohydrate 
which would remove the maximum amount of antibody from a definite volume of 
antiserum.  This is most conveniently determined by placing 2  drops of anti- 
serum in each of a series  of small tubes used for precipitin ring tests.  One drop 
of the carbohydrate in serial dilutions, ranging from  1:200  to  1:1,000,  is  added 
to each tube.  The contents of the tubes are well mixed and allowed to stand  at 
room temperature for 2 hours.  The precipitates are thrown down in the  centri- 
fuge and on the supernatant fluid is layered the carbohydrate, diluted 1:2,000. 
The original mixture of highest dilution of carbohydrate and antiserum  which 
fails to give a positive ring test is taken to indicate optimum proportion of antigen 
and antiserum.  On this basis, the amount of carbohydrate required to remove 
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the smallest possible volume of diluent.  After standing at 37°C. for 1 hour and 
overnight in the ice box, the precipitate is removed  by centrifuging  and the super- 
natant tested with the carbohydrate diluted 1:200 and 1:2,000.  If any precipi- 
tate is observed the absorption is repeated according to the procedure described 
above. 
18 hour 0.i per cent dextrose infusion  broth cultures of Type I  pneumococcus 
were  centrifuged and the deposit resuspended in a volume of saline equivalent 
to that of the broth removed.  The saline suspension was divided into two equal 
portions.  To one, sufficient  acetic acid was added to give a final concentration 
of N/100.  To the other, sodium hydroxide was added to give the same concen- 
tration of alkali.  The suspensions were then allowed to stand in the Arnold ster- 
ilizer for an hour at 100°C.  After neutralizing they were centrifuged.  Absorp- 
tion of Pneumococcus  Type I antiserum, diluted 1:4, was twice  carried out with 
the deposit from 100 cc. of the saline suspension.  The mixture of serum and 
organisms stood for 1 hour at 37°C. following  each absorption. 
EXPERIMENTAL 
A.  The Effect of the A  Carbohydrate on the Phagocytosis of Type I 
Pneumococcus in Normal Human Blood 
In this experiment, the results of which are presented in Table I, 
the effect of the A carbohydrate and its derivatives on the phagocytic 
power of normal human defibrinated blood was determined.  It was 
found that the A  carbohydrate in  a  concentration of  1:2,000  prac- 
tically eliminated the opsonic capacity of the blood, whereas the sub- 
stance after boiling in N/10 and N/50 sodium hydroxide, or the soluble 
specific substance  (SSS  I)  prepared  according to  the  procedure  of 
tteidelberger and his associates in the  same  concentration, reduced 
the count only about two-thirds.  It will also be noted that, in the 
case of the A carbohydrate, there is a definite reduction in the count 
in  a  concentration of  1:512,000  while  the  action of its  derivatives 
is not definite in concentrations above  1:8,000.  By this method of 
comparative testing, it appears  that the A  carbohydrate is  at least 
64 times as effective in removing opsonins from normal serum as the 
deacetylated polysaccharides.  The  effect of the  A  carbohydrate is 
type-specific since it has no action on the opsonic titre of the same 
blood in the presence of Type II pneumococcus.  These results possess 
an  additional interest  in  that  they elucidate  the  finding of  Ward 
and Enders (6)  concerning the failure of SSS I  to remove completely 
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Type I, even when that substance was used in as high a concentration 
as 1:400. 
TABLE I 
Type  of 
pneu]~ococcLl$  Carbohydrate 
l  0 
A 
A boiled  ~1~/50 
NaOHt 
SSS I 
Concentration of 
carbohydrate* 
1:2,000 
1:8,000 
1:32,000 
1:128,000 
1:512,000 
1:2,048,000 
1:2,000 
1:8,000 
1:32,000 
1:128,000 
1:512,000 
1:2,048,000 
1:2,000 
1:8,000 
No. of organisms 
phagocyted by 
50 ceils 
279 
12 
52 
85 
63 
120 
259 
112 
169 
290 
258 
302 
295 
132 
182 
i 
I 
I 
II 
I 
0 
A 
1:32,000 
1:128,000 
1:512,000 
1:2,048,000 
1:2,000 
218 
223 
306 
298 
616 
790 
Percentage of celia 
taking part 
98 
20 
46 
62 
58 
76 
96 
84 
90 
100 
98 
100 
100 
90 
90 
92 
96 
98 
100 
100 
100 
* Concentration  of carbohydrate present in the phagocytic system. 
t Titration of A boiled in N/10 NaOH gave counts not significantly  different 
from those for A boiled in N/50 Na0H. 
B.  The Effect of the A Carbohydrate on the Opsonin in Anti-Type I 
Pn~umococcus Serum 
Anti-Type I  pneumococcus serum,  absorbed  with  the  A  carbohy- 
drate and with that substance boiled in 1~/50 sodium hydroxide,  was 
added in suitable dilutions to normal defibrinated human blood which, 134  THE  A  SUBSTANCE  OF  PNELrMOCOCCUS  TYPE  I 
by itself,  exhibited only a  feeble phagocytic action against Type I 
pneumococcus.  The  results  are  summarized in  Table  II.  In  the 
same experiment these absorbed sera were titrated for opsonic power 
in a system containing the exudative leucocytes and defibrinated blood 
of a  normal rabbit prepared according to the method described for 
preparing this system for use in bactericidal tests.  The results were 
entirely comparable to those recorded in Table II.  From the data 
recorded therein,  it  was  calculated that  the  immune opsonin  was 
reduced in the serum absorbed with A carbohydrate to about 1.6 per 
cent of its original titre.  The deacetylated polysaccharide was less 
effective in removing the opsonin of the serum, since after absorption 
from 6.3 to 26 per cent of the antibody remained.  This difference in 
the percentages of residual antibody after absorption with deacetylated 
polysaccharide depends upon whether the counts denoting the  end- 
point of the action of the immune serum are taken as a basis for cal- 
culation  or  those  which  indicate  no  diminution  in  the  maximum 
opsonic effect, as  compared with  the  count obtained with  the  un- 
absorbed antiserum.  It is necessary to point out here that the anti- 
body,  although  greatly  reduced by  absorption  with  the  A  carbo- 
hydrate, was not completely removed.  This fact, we believe, need not 
be  explained by assuming the presence in  the  serum of any quali- 
tatively distinct antibody, but most probably may be attributed to the 
conditions upon which the reaction between antibody and the antigen 
in solution depend.  In favor of this view is the fact that suspensions 
of pneumococcus, boiled in N/100 acetic acid, have been found capable 
of removing even more opsonic antibody than the  A  carbohydrate. 
That this substance is the antigen involved, but obviously in a some- 
what different physical state, is indicated by the fact that absorption 
of the serum with organisms boiled in N/100  sodium hydroxide only 
slightly reduces its opsonic titre.  Such absorbed serum fails to pre- 
cipitate with the deacetylated polysaccharide, but reacts to titre with 
the A carbohydrate. 
On the basis of these experiments, it is apparent that the A carbo- 
hydrate is decidedly more effective in reducing both the normal and 
immune opsonin  involved in  the  phagocytosis of  Type  I  pneumo- 
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TABLE  II 
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Normal human defibfi: 
nated blood  +  sus- 
pension ofType I 
pneumococcus 
Anti-Type I 
pneumococcus 
Seruln 
0 
Unabsorbed 
Absorbed with A 
Absorbed withA 
bo~edinN/50 
NaOH 
Dilution of 
antiserum 
1:256 
1:1,024 
1:4,096 
1:16,384 
1:1 
1:4 
1:16 
1:64 
1:256 
1:4 
1:16 
1:64 
1:256 
1:1,024 
1:4,096 
No. organisms 
phagocyted 
by 50  cells 
66 
502 
396 
162 
100 
460 
482 
333 
161 
80 
506 
770 
524 
216 
97 
69 
Percentage of 
cells  taking 
part 
50 
100 
100 
96 
74 
96 
100 
98 
88 
62 
100 
100 
100 
94 
76 
60 
C.  The Effect of the A  Carbohydrate on the Bactericidal Action of Normal 
Human Blood 
Employing the defibrinated blood of the same normal individual 
which formed the base for the opsonic experiment, the antibactericidal 
action of the A carbohydrate was compared with that of SSS I, pre- 
pared according to the method of Heidelberger,  Goebel and Avery. 
The results recorded in Table III parallel those obtained using the 
opsonic technique.  It is evident that the bactericidal action of blood 
is significantly depressed by as small a concentration of the A carbo- 
hydrate as  1:512,000.  The concentration of SSS I  required to pro- 
duce the same inhibition of bactericidal capacity is  1:32,000 which 
represents at least a sixteenfold decrease in activity.  It will be noted 
that the A carbohydrate does not significantly influence the capacity of 
the same blood to kill Type II pneumococcus.  Essentially similar find- 
ings have been recorded in a comparison of the antibactericidal effect of 
the A carbohydrate and that substance after boiling in N/10 sodium 
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TABLE III 
Type  of pneumococcus  Carbohydrate  Concentration of  Approximate No,  carbohydrate  pneumococci  killed 
by 0.25 ce. bloo¢[ 
--  40,000 
II 
I  0 
SSS I 
A 
0 
A 
1:2,000 
1:8,000 
1:32,000 
1:128,000 
1:2,000 
1:8,000 
1:32,000 
1:128,000 
1:512,000 
1:250 
40 
40O 
400 
40,000 
0 
4 
4 
40 
40O 
400,000 
40,000 
D.  The Effect of the A  Carbohydrate on the Bactericidal Action of Anti- 
Type I  Pneumococcus  Rabbit Serum 
The determination of the effect of the A carbohydrate on the bac- 
tericidal action of anti-Type I pneumococcus rabbit serum was carried 
out in two different ways.  In one, a suitable dilution of the antiserum 
was chosen and held constant while the quantity of A carbohydrate or 
its deacetylated derivative was varied.  In the other type of experi- 
ment,  the  antiserum was  absorbed  with the  A  carbohydrate or  its 
derivative and serial dilutions of these absorbed sera were tested for 
bactericidal power.  In both cases a mixture of exudative leucocytes 
and defibrinated blood of the normal rabbit was used as the basis of 
the  system.  Both methods of testing showed that the A  carbohy- 
drate was several times more efficient in impairing the ability of the 
antiserum to  promote  the  destruction of  the  pneumococcus in  the 
presence  of fresh normal serum  and polymorphonuclear leucocytes. 
It is, however, to be emphasized that by the method of absorption it 
was found that in every case a not inconsiderable amount of the anti- 
body involved in  the  destruction of the  organism remained.  This 
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TABLE  IV 
Experiment I 
Effect of Carbohydrates on Constant Dilution of Anti-Type I  Pneumococcus Rabbit 
Serum 
Concentration of 
antiserum 
1:2,000 
Carbohydrate 
0 
0 
A 
A  boiled in N/50 
NaOH 
Concentration of 
carbohydrate 
1:2,700 
1:8,000 
1:16,000 
1:32,000 
1:64,000 
1:128,000 
1:2,700 
1:8,000 
Approximate No. 
pneumococcl  killed 
70,000 
0 
7 
700 
700 
7,000 
70,000 
7,000 
70,000 
Experiment II 
Bactericidal  Action of Anti-Type I  Pneumococcus  Rabbit Serum Absorbed 
w#h Carbohydrates 
Antiserum absorbed with  Approxlm~tekNllOegneumococci  carbohydrate  Concentration of antiserum 
0 
Unabsorbed 
A 
A boiled in N/50 NaOH 
1:8,000 
1:32,000 
1:128,000 
0 
7,000 
7OO 
0 
1:32 
1:128 
1:500 
1:2,000 
1:500 
1:2,000 
1:8,000 
1:32,000 
70,000 
700 
70 
0 
70,000 
70 
7 
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system was  expected from the  results  obtained when  similarly ab- 
sorbed serum was tested for residual opsonin and, we are inclined to 
believe, is due to the same cause that we have previously postulated. 
In discussing these experiments, it is important to note the fact that it 
proved impossible--using the constant dilutions of antiserum  1:250 
and  1:500--to  show  any significant  effect of the  deacetylated car- 
bohydrate in the highest concentration used (i.e.,  1 : 2,700) on the bac- 
tericidal property of these quantifies of antiserum which, however, were 
definitely impaired by dilution of the A carbohydrate in concentrations 
ranging from 1 : 16,000  and 1 : 32,000.  In Table IV the results of two 
experiments among several carried out are summarized.  They sup- 
port the observations already described in showing that the A carbo- 
hydrate is about sixteenfold more active in removing antibody than 
is the deacetylated polysaccharide.  Nevertheless, it requires approxi- 
mately equal concentrations of antiserum and A  carbohydrate before 
complete inhibition of the bactericidal action is obtained.  The type 
specificity of the action of the highest concentration of A carbohydrate 
was assured by adding it  to Type III pneumococcus, together with 
diluted  anti-Type  III  pneumococcus  serum.  It  exerted  no  anti- 
bactericidal effect in this system. 
E.  The Effect on the Mouse-Protective Action of Anti-Type I  Pneumo- 
coccus Rabbit Serum Absorbed  with the A  Carbohydrate 
Although repeated efforts were made to show that the A  carbohy- 
drate would remove all protective action for mice  from anti-Type I 
pneumococcus rabbit serum, none were completely successful.  From 
the data recorded in Table V, it is clear that absorption with the A 
carbohydrate markedly reduces the protective titre of the antiserum. 
It is difficult, because of the small number of animals involved,  to 
assess precisely  the extent of this reduction, but if one selects the highest 
dilution of serum which protects three out of three mice as a basis for 
calculation, it will be found that absorption with A  has lowered the 
titre to 1.5 per cent of its original value, compared with a  reduction 
to  6.2  per  cent  after  absorption  with  the  deacetylated compound. 
These figures indicate that the A  carbohydrate is  about four times 
more  effective in  removing  the  protective  titre  of  the  antiserum. 
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absorption was boiled in N/10 NaOH yield comparable results.  Thus, 
the protection test  carried out with serum  absorbed with A  and  its 
derivatives  shows  less  difference in  activity  between  them  than  is 
revealed either by the bactericidal or opsonic techniques.  However, 
a greater discrepancy in absorptive capacity is found if portions of the 
serum previously saturated with Type I pneumococcus boiled in N/100 
TABLE  V 
Effect on the Mouse-Protective Titre  of Anti-Type I  Pneumococcus Rabbit Serum 
Absorbed with  the  A  Carbohydrate 
Dilution of antiserum... 
Unabsorbed serum 
Serum absorbed with A 
Serum absorbed with  A  boiled 
in N/50 NaOH 
Serum absorbed with  Pneumo- 
coccus I boiled in N/100 HAc 
Serum  absorbed  with  Pneumo- 
coccus I boiled in N/100 NaOH 
1:4  1:16  1:64 
Not done Not done Not done 
S 
S 
D 
S 
S 
D 
S 
S 
D 
S 
D 
D 
S 
S 
D 
D 
D 
D 
1:256  1:1,024 
s  D 
S  D 
S  D 
D  Not done 
D 
D 
S  D 
D  D 
D  D 
Not done Not done 
S  S 
S  D 
S  D 
Three mice received the same dilution of antiserum. 
D  -- died.  S -- survived. 
acetic acid and N/100 sodium hydroxide are tested for their protective 
titre in mice.  The results of an experiment of this kind are included in 
Table V.  It will be seen that absorption with pneumococci boiled in 
alkali  does not  definitely affect the  protective action  of the  serum, 
although this treatment had removed all precipitating antibody react- 
ing with the deacetylated carbohydrate.  In contrast, absorption with 
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protective action.  There can be little doubt that it is the A  carbo- 
hydrate present in the pneumococcus upon which the removal of the 
antibody depends. 
This failure to eliminate completely the mouse-protective action of 
an antiserum by addition of the A carbohydrate is not in entire agree- 
ment with the findings of Avery and Goebel (4).  In addition to the 
possibility which has already been discussed concerning the physical 
state of the antigen, the discrepancy may be either in the fact that 
these authors did not test serum less dilute than 1:10, or that they 
employed antipneumococcus horse serum, while we used antipneumo- 
coccus rabbit serum.  Powell and his coworkers (9) have shown that 
heterophile  antibody  of  Forssman, together with very small quan- 
tities of specific pneumococcus antibody, greatly increases the thera- 
peutic properties of the serum in rabbits.  Since the Forssman anti- 
body may be present in antipneumococcus rabbit serum, it is possible 
that its presence in the antiserum employed might account for this dif- 
ference in results. 
F.  The Antigenic Action of the A  Carbohydrate 
It has been found that when comparatively large amounts of the 
A carbohydrate are injected into mice no immunity against virulent 
Type I  pneumococcus develops.  If the quantity  of carbohydrate is 
decreased,  definite, though limited resistance to  infection develops. 
Boiling the A carbohydrate in N/10 sodium hydroxide removes com- 
pletely  its  capacity  to  function  as  a  complete  antigen.  Similar 
treatment in N/50 sodium hydroxide appears to only partially destroy 
the  antigenic property of the  substance.  Briefly  summarized, the 
experimental findings were as follows: Nine mice were vaccinated by 
three intraperitoneal injections of 0.00025 rag. of the A carbohydrate, 
administered every 3rd day, and infected with 0.5 cc. doses of Pneu- 
mococcus Type I, increasing by tenfold from 1:1,000,000 to 1: 10,000 
dilution of broth culture, on the 6th day after the last dose of the 
carbohydrate.  Two only, of the nine mice, died with pneumococci 
in the heart's blood.  These animals had received the largest number 
of organisms.  Out of four mice vaccinated in the same manner, with 
equivalent  quantities  of  A  boiled  in  N/50  sodium hydroxide,  two 
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hydroxide  and  infected  with  doses  of  pneumococci ranging  from 
1:100,000,000 to  1: 100,000, all died. 
Quantities of A as large as 8 rag. given at 3 day intervals, in doses of 
2 rag. each, failed to confer any protection on the 11th day after the 
last injection.  It was thought that if a longer period was allowed to 
elapse,  subsequent to  the  course of immunization with  such  large 
doses,  before the  animals were infected, immunity might develop. 
Accordingly, an interval of 6 weeks was allowed before infecting two 
mice, one of which had received 1 rag. and the other 2 rag. of the A 
carbohydrate.  No indication of resistance was observed.  Additional 
confirmation of the fact that large doses  of the A carbohydrate fail 
to immunize is given in Table IV. 
It was believed unnecessary to present these experiments in greater 
detail, since they fully confirm those of Avery and Goebel (4). 
We have noted that  extremely small  quantities of the A  carbo- 
hydrate may actively immunize mice: 0.5 cc. of 1:10,000,000 dilution 
of the material (i.e., 0.00005 rag.), administered intraperitoneally, at 
a single dose,  will protect a certain percentage of the animals under 
test, against at least 10 M. L. D.'s of virulent pneumococci.  Increasing 
the immunizing dose tenfold appears to improve slightly the immunity 
obtained.  This dose of 0.0005 rag. proved to be about the optimum, 
since a further increase to 0.005 rag. is definitely  less effective.  Larger 
amounts of the A carbohydrate produce practically no resistance to 
infection.  There is a suggestion that with a dose of 0.005 rag. some 
immunity may develop within 24 hours.  After 3 days 50 per cent 
of the mice vaccinated with 0.00005 and 0.0005 rag. showed resistance. 
Maximum immunity exists from 6 to 25 days after vaccination, but 
apparently is  in a  state of defervescence by the 49th  day.  These 
statements are based on the experimental results included in Table VI. 
The manner of procedure was as follows:  60 normal mice were divided 
into five lots.  The twelve mice in each lot were injected intraperi- 
toneally with  the  same  dose  of  A  carbohydrate.  The  quantities 
received by the various lots of mice ranged from 0.00005 mg. to 0.5 
rag.  At varying intervals after vaccination, two mice were selected 
from each lot  and injected intraperitoneally with the  same dose of 
Type I pneumococci, which was equivalent to at least 10 ~. L.D.  In 
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TABLE  VI 
Amount of A 
Lot No. of  used for 
mice  vaccination 
rag. 
1  0.00005 
2  0.0005 
3  0.005 
4  0.05 
5  0.5 
Normal  mice  injected 
intraperitoneally with 
0.5 co. 1:10,000,000 
culture  Pneumococ- 
cus I 
Two mice from each lot injected iutraperitoneally with 0.5 cc. culture 
Pueumococcus I  diluted  1 : 1,000,000 
Days after vaccination on which mice were infected 
3  6  12  25  49  1 
D 24 
D48 
D 48 
S 
D 48 
D60 
D48 
D48 
D 24 
D48 
D 48 
D40 
S 
D40 
D 70 HB-- 
D40 
D 48 
D40 
D48 
D40 
D 36 
D 36 
D 98 HB-  D 60  S  D 36 
S  S  S  D60 
D  48  S  D  144  D 36 
S  S  S  S 
D48  D60  D  60  D36 
S  S  S  S 
D 48  D 36  S  D 36 
D60  D36  D  36  D36 
D24  D36  D  36  D44 
D48  D36  D  36  D44 
D48  D36  D  60  D60 
D  =  died; numerals following indicate number of hours after infection in which 
death occurred.  S  -~  survived.  HB-  =  heart's blood culture negative.  In 
all cases not indicated, culture of heart's blood was positive for pneumococcus. 
G.  Elimination  of Immunity Induced by  Vaccination with the A 
Carbohydrate 
It became  of interest  to ascertain  whether  the  immunity  resulting 
from vaccination with  the  A  carbohydrate  could  be  annulled  by in- 
jecting that  substance  just prior to infection with the pneumococcus. 
Five mice were given three injections of 0.00025 rag. intraperitoneally, 
every 3rd day.  9 days after the last injection, three of the mice were 
injected intraperitoneally  with 0.5 rag. of the A  carbohydrate.  Mter 
an  interval  of 4½  hours,  these  animals,  together  with  the  two  which 
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treatment with A, were infected with 0.5 cc. of Pneumococcus Type I 
culture,  diluted  1:1,000,000.  A  normal mouse was injected at  the 
same time with 0.5 cc. of a  1 : 10,000,000  dilution of the same culture. 
The three mice which received 0.5 rag. of A  before infection all died 
within 3  days, together with  the normal control.  Of the two vac- 
cinated mice which had not received 0.5 rag. of A before infection, one 
survived 6 days and the other was killed after 7 days.  Preliminary 
injection, then, of a  comparatively large quantity of the A substance 
shortly before infection appears to remove the protective mechanism 
developed in response to small doses of the same material previously 
administered. 
H. Passive Transfer of Immunity Developed in Response to Injection 
of the A Carbohydrate 
The question arose as to whether demonstrable antibody appeared 
in response to vaccination with the A  carbohydrate in the serum of 
the  mouse.  Eight  mice  were  immunized  at  the  same  time,  and 
according to the procedure in the preparation of animals used in the 
previous experiment.  10 days after the last immunizing dose of the A 
carbohydrate was given, the mice were bled from the heart under ether 
anesthesia, employing a tuberculin syringe and a 27 gauge hypodermic 
needle.  The blood was pooled and allowed to clot.  About 4  cc. of 
serum were obtained.  Four normal  mice were each  injected  intra- 
venously with 0.75  co. of this pooled serum.  At the same time, two 
normal mice were injected, by the same route, with 0.75  co.  of the 
pooled serum of four normal mice.  Mter  an interval of 20  hours, 
these six animals were infected intraperitoneally with 0.5 cc. of Type I 
pneumococcus culture,  diluted  1:1,000,000.  A  normal  mouse  was 
injected with  0.5  cc.  of  1:10,000,000  dilution  of the  same  culture. 
The results which are presented in Table VII show dearly that the 
serum of mice immunized with the A carbohydrate contains substances 
protective against Type I pneumococcus. 
With  the remainder of the pooled serum obtained from the mice 
vaccinated with  the A  carbohydrate,  tests  for  the  presence of  ag- 
glufinins for Pneumococcus Type I  and precipitins for the A  carbo- 
hydrate were carried out.  In both cases the results, entirely negative, 
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TABLE  VII 
Passive Transfer  of Protectire Substance in Serum of Mice  Vaccinated with the A 
Carbohydrate 
Dilution of infecting 
Mouse  Pooled serum A-  Pooled  serum nor-  dose Pneumococcus I  Result 
vaccinated mice  msl mice  (0.5 o~.) 
C6. 
0.75 
0.75 
0.75 
0.75 
0 
0 
0 
o 
o 
o 
o 
o.75 
075 
o 
1:10,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:10,000,000 
S 
S 
S 
S 
D 
D 
D 
Serum administered intravenously, pneumococcus culture intraperitoneally 
20 hours after serum was given. 
DISCUSSION 
In general the experimental evidence presented shows that the A 
carbohydrate, which, on the basis of chemical analysis and biological 
action, is to be identified with the acetyl polysaccharide of Avery and 
Goebel, is distinctly more effective than the deacetylated derivative 
in reducing the efficiency of the several immunological systems which 
have been studied.  The A carbohydrate, then, closely approaches, if 
indeed it be not identical with the substance developed by Type I 
pneumococcus which enables  the  organisms to  resist  the  defensive 
mechanisms of the host, in so far as these are type-specific. 
Capable, like the organism itself, of inducing resistance to subse- 
quent  infection,  as  Avery  and  Goebel  have  shown  for  the  acetyl 
polysaccharide,  the  A  carbohydrate,  introduced  parenterally  into 
mice, arouses a  state of active immunity which may appear as early 
as the 3rd day after vaccination.  This immunity, closely correlated 
with  the  quantity  of  carbohydrate  employed--since doses  of  over 
0.005  mg. fail to protect--is not of great magnitude nor of marked 
duration.  It may be completely eliminated by introducing into the 
body of the vaccinated mouse an appropriate amount  of  A  carbo- 
hydrate shortly before infection'.  That such resistance is dependent 
upon substances which may appear in  the serum has been demon- 
strated by the passive transfer of the immune state to normal mice 
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Perhaps the chief interest and value of these experiments with the 
A carbohydrate and those of Goebel and Avery with the acetyl poly- 
saccharide lie in their application to our ideas on the nature of antigens. 
It is extremely improbable that the acetylated carbohydrate contains 
even a  minute  quantity  of protein, yet it  functions as  a  complete 
antigen,  in  that  it  not  only  actively  immunizes the  animal  body 
against  subsequent invasion by the homologous organism, but  also 
gives rise to demonstrable protective substances in the serum.  Ten- 
tatively, it would seem that the conception of all complete antigens 
as being protein in nature should be modified. 
There is a question which has been in our minds during the course 
of this work and which still remains unanswered: Is there one anti- 
body which reacts in a  quantitatively different manner with the A 
carbohydrate and the deacetylated compound, or are there two anti- 
bodies corresponding to the two forms of the antigen?  Against the 
acceptance of the first alternative is the fact that a serum containing 
a high titre of precipitin reacting with the A carbohydrate may fail 
entirely to precipitate with the deacetylated material.  On the other 
hand, there is ample evidence to show that the introduction into an 
antigen of chemical groupings, no more complex than the acetyl group, 
may definitely change the specificity.  However, if two antibodies are 
postulated,  it would be necessary, in view of experimental fact,  to 
assume that the A carbohydrate could unite with both, whereas the 
deacetylated carbohydrate could react with only that antibody specifi- 
cally produced in response to its antigenic stimulus. 
In this connection, the experiments of Avery, Goebel and Babers 
(10) on the serology of artificially prepared antigens containing sub- 
stituted glucosides present an interesting analogy to the behavior of 
the A carbohydrate and the deacetylated substance.  These authors 
showed  that  an  antiserum  prepared  by  injecting  p-aminophenol 
a-glucoside linked to globulin was precipitated by both p-aminophe- 
no[ a-glucoside-globulin and p-aminophenol 3-glucoside-globulin.  If 
p-aminophenol a-glucoside was added to this antiserum, precipitation 
was inhibited in the presence of  both  ~-and 3-glucosides linked to 
globulin.  However,  addition  of  3-glucoside inhibited  precipitation 
only against p-aminophenol 3-glucoside linked to globulin.  Since in 
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indicate that the difference in reaction capacity of the A carbohydrate 
and the deacetylated product could be explained on the assumption 
that only a single antibody was involved. 
SUMMARY 
I.  The  A  carbohydrate  isolated  from  Type  I  pneumococcus by 
Pappenheimer and Enders, on the basis of elementary analysis, the 
presence of the acetyl group and its immunological properties, appears 
to be identical with the acetyl polysaccharide described by Avery and 
Goebel. 
2.  The A carbohydrate possesses a greater anti-opsonic action than 
either the deacetylated substance obtained by boiling in alkali or the 
soluble specific substance of Type I pneumococcus prepared according 
to the procedure of Heidelberger,  Goebel and Avery.  The opsonic 
titre of normal human serum is practically eliminated upon the addi- 
tion of the A  carbohydrate--an effect not observed with equivalent 
amounts of either the deacetylated material or the specific soluble 
substance.  In immune serum,  the A  carbohydrate brings  about  a 
quantitatively greater reduction in opsonic activity than its deriva- 
tives, but it has not been possible to demonstrate complete inhibition 
of phagocytic action by the method of absorption of antibody. 
3,  In a  system of normal human serum and leucocytes capable of 
destroying Type I pneumococcus,  the bactericidal effect may be entirely 
removed upon the addition of the A  carbohydrate.  It proved im- 
possible to  inactivate the bactericidal  action with the deacetylated 
substance in equivalent proportions.  In  this system, the A  carbo- 
hydrate was about 64 times more effective as an antibactericidal agent 
than  the  deacetylated  compound.  Essentially  similar  results were 
obtained in a study of the antibactericidal properties of the A carbo- 
hydrate and the deacetylated derivative in the presence of anti-Type I 
pneumococcus  rabbit serum added to a mixture of exudative leucocytes 
and the defibrinated blood of the rabbit. 
4.  The mouse-protective titre of anti-Type I  pneumococcus rabbit 
serum is  lowered to  a  greater  degree  after  absorption with the  A 
carbohydrate than it is by similar treatment with the deacetylated 
compound.  Absorption with the A carbohydrate does not, however, 
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5.  As Avery and Goebel have shown in the case of the acetyl poly- 
saccharide, so the A  carbohydrate, when administered in very small 
quantities,  protects mice against an otherwise fatal dose of Type I 
pneumococcus.  Active immunity in mice has been obtained with as 
little as 0.00005  rag. of the A  carbohydrate administered in a  single 
dose.  Doses  larger  than  0.005  rag.  confer no  protection  on  these 
animals.  Deacetylization of the A carbohydrate after boiling in •/10 
sodium  hydroxide destroys its protective capacity while similar treat- 
ment in N/50 alkali does not completely remove its immunizing prop- 
erty.  Active immunity may arise within  3  days  following a  single 
injection of the A substance.  It appears to be  at  its  height from 6 
to 25 days thereafter, and is  retrogressive  by  the  49th  day  follow- 
ing  vaccination.  Injection  of the  A  carbohydrate into  immunized 
mice immediately before infection deletes the state of resistance. 
6.  The immunity actively induced as a result of injection of the A 
carbohydrate may be passively transferred to normal mice with the 
serum of vaccinated animals. 
7.  Since the evidence obtained in the course of this study indicates 
that  the  A  carbohydrate of  Type  I  pneumococcus and  the  acetyl 
polysaccharide of  Avery and  Goebel  represent  the  same  chemical 
substance, it is suggested that the designation "A carbohydrate" or 
"A substance" be relinquished in favor of the more exactly descriptive 
term "acetyl polysaccharide." 
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